ABCC1 and acute myeloid leukemia: Accordingly, recipients of MOLM-13 ABCC1-knockout cells harbored significantly less AML cells in their bone marrow upon AZD-4320 treatment than mice transplanted with MOLM-13 AAVS1.1 control cells (Fig. 3F).